Combination of Trunk Mobilization and Neuro Development Treatment against Spasticity Reduction of Spastic Type Cerebral Palsy Siti Sarah Bintang*, Miftahul Zannah, Isidorus Jehaman, Elsaria Br Sembiring, Raynald Ignasius Ginting and Sabirin Berampu *Faculty of Nursing and Physiotherapy, Institut Kesehatan Medistra Lubuk Pakam, Indonesia Keywords: Cerebral Palsy, Spastisitas, Mobilisasi Trunk, Neuro Development Treatment Abstract: Spastic cerebral palsy is a type of brain damage that occurs in the extreme part of the pyramids that results in an increase in reflexes that make muscle tone higher than normal. This study aims to look at the effect of a combination of Trunk Mobilization and Neuro Development Treatment on reducing spasticity in spastic type cerebral palsy children. The research design used was one group pre and post test design. Test Results for the results of reducing spasticity in cerebral palsy children before and after the intervention of Trunk Mobilization and Neuro Development Treatment, it can be seen that the value of p = 0.157 which means greater than 0.05 (p> 0.05) so that the null hypothesis (Ho) accepted and the alternative hypothesis (Ha) was rejected. So the conclusion with the acceptance of Ho means there is no effect of a combination of Trunk Mobilization and Neuro Development Treatment to reduce spasticity in children with cerebral palsy after intervention. 1 INTRODUCTION Cerebral palsy or abbreviated (CP) is a disability that was first raised by William Little in the 1840s. This condition is a diagnostic and therapeutic challenge which is quite large (Bajraszewski, 2014). There are mild degrees with minimal disabilities up to severe degrees. Disability that occurs for a lifetime, will generally be the cause of autism and mental retardation which causes difficulties for the impact on their individuals and families (Myoung and MPH, 2017). Cerebral palsy is a disorder of motion and attitude. This is defined as a non progressive disorder of posture, motor disturbances and secondary disorders that occur due to lesions or anomalies that occur in the brain that arise in the early stages of development. Primary lesions or static injuries will affect the growth and development of plasticity and maturity of the central nervous system (Myoung and MPH, 2017). Cerebral palsy occurs worldwide 2-2.5/1000 births. One cause is trauma at birth, and the progress of neonatal management has not been able to show a decrease in the incidence of CP patients (Ryan and Sandra, 2011). The neurologic impairment is nonprogressive, although secondary disability can occur. Characteristics of cerebral palsy change with developmental stages, especially in the first few years of life. This impairment and resultant disability are both permanent (Bosanquet, 2013). The prevalence of people with Cerebral Palsy at birth is based on research data from health care centers in the United States from mild to severe ranging from 1.5 to 2.5 per 1000 live births. Research data on school-age children, the prevalence of cerebral palsy found 1.2 - 2.5 children per 1,000 population. At least 5,000 new cases of cerebral palsy occur each year. From these cases 10% to 15% of cerebral palsy found a brain disorder that is usually caused by infection or trauma after the first month of life (Surakarta,2013). The incidence of cerebral palsy patients in Indonesia based on data from the Ministry of Health in 2011 is estimated to be around 1 - 5 per 1,000 live births and the number of people with disabilities is around 7-10% of Indonesia's population. More men than women. Generally found in the first child. The incidence rate is higher in babies born prematurely, twin births and mothers who are over 40 years old. Almost half this disability is experienced in children Bintang, S., Zannah, M., Jehaman, I., Sembiring, E., Ginting, R. and Berampu, S. Combination of Trunk Mobilization and Neuro Development Treatment against Spasticity Reduction of Spastic Type Cerebral Palsy. DOI: 10.5220/0009840304830490 In Proceedings of the International Conference on Health Informatics and Medical Application Technology (ICHIMAT 2019), pages 483-490 ISBN: 978-989-758-460-2 Copyright c  2020 by SCITEPRESS – Science and Technology Publications, Lda. All rights reserved 483